Last reviewed · How we verify
Single dose of HDM1002 on Day 1 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Single dose of HDM1002 on Day 1 (Single dose of HDM1002 on Day 1) — Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Single dose of HDM1002 on Day 1 TARGET | Single dose of HDM1002 on Day 1 | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Single dose of HDM1002 on Day 1 CI watch — RSS
- Single dose of HDM1002 on Day 1 CI watch — Atom
- Single dose of HDM1002 on Day 1 CI watch — JSON
- Single dose of HDM1002 on Day 1 alone — RSS
Cite this brief
Drug Landscape (2026). Single dose of HDM1002 on Day 1 — Competitive Intelligence Brief. https://druglandscape.com/ci/single-dose-of-hdm1002-on-day-1. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab